FAS Diagnostic

The Siemens Atellica VTLI

A Vital Leap Forward in Cardiac Testing

When a patient enters the emergency department presenting with the symptoms of a myocardial infarction (MI), every moment is critical. Achieving favorable clinical and operational outcomes requires fast and accurate chest pain assessment at the point of care, as well as coordination with the laboratory for quality assurance. Having high-sensitivity troponin testing at the point of care—producing accurate results in just 8 minutes—could transform care delivery for millions of people each year, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimizing the use of time and resources of busy laboratories.

SEBIA Alegria System

The frontier in Autoimmune Testing. Any Test, Any Time

The fully automated Alegria^® and Alegria^® 2 systems provide a cost-effective solution with ORGENTEC’s unique and comprehensive Autoimmune and Specialty Infectious disease panel utilizing the Alegria^® Monotest technology. This technique enables you to test individual and customized patient profiles as needed for optimized patient care.

Each individual Alegria^® Monotest strip contains a complete set of reagents for determination of single patient results. Since every* Alegria^® Monotest strip runs with the same protocol, high flexibility is guaranteed for your customized patient profile set up. Any combination of any available Alegria^®* test out of the large menu with more than 130 assays, can be chosen to run your patient-profiles in an efficient and quick way.

Furthermore, each result is validated with its own integrated control and built-in calibration utilizing the SMC^® Technology (Sensotronic Memorized Calibration), for full trust in your result.

STA® -Liatest

As part of Stago’s continuous improvement commitment, STA® -Liatest® D-Di Plus* was developed as an evolution of the STA® -Liatest® D-Di, one of the most published D-Dimer assays, also FDA approved for aid in the diagnosis of Venous ThromboEmbolism (VTE).

n STA® -Liatest® D-Di Plus, the addition of a blocking agent improves the analytical and diagnostic performances of the assay by minimizing interferences to heterophilic antibodies, including rheumatoid factors (RF) and Human Anti-Mouse Antibodies (HAMA).

Less Interferences for more efficacy

Immunoassays, which are commonly used in the diagnostic testing, may be prone to interferences with heterophilic antibodies, when present in patient plasmas. The prevalence of these interferences with D-Dimer assays in the diagnosis of VTE is low but may cause an overestimation of the result.

Atellica CI 1900

The Atellica CI Analyzer addresses big challenges—all in a compact 1.9m² footprint.

The weight of the responsibility you carry in the lab, and the enormity of the challenges you face to deliver quality testing– quickly, consistently, and accurately – day after day, is constant. Labs of all sizes are being asked to do more with less. This calls for more than a one-size fits all approach. The Atellica® CI Analyzer addresses these issues head-on—achieve predictable patient care, deliver greater agility across your network and meet security and sustainability goals – all in a compact 1.9m² footprint.